Amyloid β-oligomers have been reported to prevent the accumulation of SynGAP at the PSD, where its loss is one of the most significant changes in an early stage tauopathy model [11]; accordingly, SynGAP may play a role in Alzheimer’s disease. Here, SYNGAP1 is linked to tauopathy.